Medical Conditions

Patent Ductus Arteriosus (PDA) in Babies

The short answer

Patent ductus arteriosus (PDA) occurs when the ductus arteriosus — a blood vessel that normally closes shortly after birth — remains open. It is very common in premature babies, occurring in about 60% of babies born before 28 weeks. In full-term babies, a PDA is less common but can occur. Small PDAs may close on their own. Larger PDAs can be closed with medication, catheter procedures, or surgery, with excellent outcomes.

By Age

What to expect by age

In premature babies, a PDA is often detected in the first days of life by echocardiogram, especially if the baby requires respiratory support. A characteristic "machinery-like" continuous heart murmur may be heard. Treatment options for premature babies include medications (indomethacin or ibuprofen) to promote closure, catheter-based closure, or surgical ligation. In full-term babies, a small PDA may be detected as an incidental murmur and often closes on its own within the first few months.

By this age, many small PDAs in full-term babies have closed spontaneously. If the PDA remains open but is small and causing no symptoms, watchful waiting continues. A moderate or large PDA that is causing symptoms — rapid breathing, difficulty feeding, poor weight gain, or bounding pulses — may need intervention. Catheter-based closure with an occluder device is now a preferred approach in many centers.

A persistent PDA that has not closed spontaneously is typically recommended for closure to prevent long-term complications such as pulmonary hypertension and heart failure. Even if the baby is asymptomatic, closure is generally recommended for moderate to large PDAs. The catheter-based closure procedure has a very high success rate and minimal recovery time.

After PDA closure — whether spontaneous, by catheter, or by surgery — children are expected to have a completely normal heart and no activity restrictions. Follow-up echocardiograms confirm successful closure. Very small PDAs that are hemodynamically insignificant may be monitored rather than closed, but most pediatric cardiologists recommend closure to eliminate the small risk of endocarditis.

What Should You Do?

When to take action

Probably normal when...
  • Your baby's PDA was small and closed on its own within the first few months
  • Your premature baby's PDA closed with medication (indomethacin or ibuprofen)
  • Your baby had a successful PDA closure procedure and is growing and developing normally
  • Your baby has a tiny PDA that the cardiologist considers hemodynamically insignificant
Mention at your next visit when...
  • Your baby has a heart murmur that was described as continuous or "machinery-like"
  • Your baby with a known PDA is breathing fast, sweating with feeds, or not gaining weight
  • Your premature baby's PDA did not close with medication and further treatment is being discussed
Act now when...
  • Your baby is breathing very rapidly, appears in distress, or has a blue or gray color
  • Your premature baby with a PDA develops worsening respiratory status requiring increased oxygen or ventilator support

Sources

My Baby's Head Shape Looks Abnormal

Many babies develop temporary head shape irregularities that are completely normal. A cone-shaped head from vaginal delivery reshapes within days. Mild positional flattening (plagiocephaly) from sleeping on the back is very common and usually improves with repositioning and tummy time. However, head shape changes involving ridges, a persistently bulging fontanelle, or rapid head growth changes should be evaluated to rule out craniosynostosis.

Achondroplasia (Dwarfism) in Babies

Achondroplasia is the most common form of short-limbed dwarfism, affecting about 1 in 15,000 to 40,000 births. It is caused by a mutation in the FGFR3 gene and is usually apparent at birth with characteristic features including short limbs, a larger head, and a prominent forehead. Intelligence is normal. With monitoring for specific complications and supportive care, children with achondroplasia lead full, active, and independent lives.

Adenoid Hypertrophy and Breathing

Adenoids are lymphoid tissue located behind the nose that help fight infection in young children. When adenoids become enlarged (adenoid hypertrophy), they can block the nasal airway, causing chronic mouth breathing, snoring, nasal speech, and sleep-disordered breathing. Enlarged adenoids are most common between ages 2-7 and are a leading cause of obstructive sleep apnea in young children. Treatment ranges from watchful waiting and nasal steroids to surgical removal (adenoidectomy) if breathing or sleep is significantly affected.

Air Quality and Baby Health

Babies and young children are more vulnerable to air pollution than adults because they breathe faster, their lungs are still developing, and they spend more time close to the ground where some pollutants concentrate. The EPA recommends keeping babies indoors when the Air Quality Index (AQI) exceeds 100 (orange level). During wildfire smoke events, keep windows closed, use air purifiers with HEPA filters, and monitor your child for coughing, wheezing, or difficulty breathing. Long-term exposure to air pollution can affect lung development.

Altitude Sickness in Babies

Babies and toddlers can experience altitude sickness when traveling above 5,000-8,000 feet (1,500-2,500 meters). Symptoms are harder to recognize in infants because they cannot describe how they feel. Watch for unusual fussiness, poor feeding, disrupted sleep, vomiting, and fast breathing. Gradual ascent is the best prevention. Most pediatricians recommend avoiding sleeping at very high altitudes (above 8,000 feet) with infants when possible, and descending immediately if symptoms appear.

Amblyopia (Lazy Eye) Treatment Timing

Amblyopia (lazy eye) is the most common cause of vision loss in children, affecting 2-3% of the population. It occurs when one eye develops weaker vision because the brain favors the other eye. Early detection and treatment are critical because the visual system is most responsive to treatment during early childhood. Treatment is most effective when started before age 7, though improvement is possible at older ages. Treatment options include patching the stronger eye, atropine eye drops, glasses, or a combination.